Skip to main content
Erschienen in: Clinical and Experimental Nephrology 6/2014

01.12.2014 | Original Article

An association between serum γ-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey

verfasst von: Toshihiro Ishigami, Ryohei Yamamoto, Yasuyuki Nagasawa, Yoshitaka Isaka, Hiromi Rakugi, Kunitoshi Iseki, Kunihiro Yamagata, Kazuhiko Tsuruya, Hideaki Yoshida, Shouichi Fujimoto, Koichi Asahi, Issei Kurahashi, Yasuo Ohashi, Toshiki Moriyama, Tsuyoshi Watanabe

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The association between alcohol consumption and chronic kidney disease (CKD), characterized by reduced glomerular filtration rate and proteinuria, is controversial. Recent studies suggest that serum γ-glutamyltransferase (GGT) level, a conventional marker of excessive alcohol consumption, predicts the CKD incidence. Little information is available on the difference in the clinical impact of alcohol consumption and GGT on proteinuria.

Methods

The present cross-sectional survey included 332,296 Japanese people aged ≥40 years in 2008. To examine the associations of GGT and alcohol consumption with proteinuria, 134,600 men and 197,696 women were classified into 20 categories based on GGT quartiles and alcohol consumption categories, and their prevalence rate ratios (PRR) of proteinuria defined as ≥1+ of dipstick urinary protein were calculated after adjusting for clinically relevant factors.

Results

Prevalence of proteinuria was 7.5 and 3.7 % in men and women, respectively. In both gender an association between alcohol consumption and proteinuria was in a J-shaped fashion with the lowest PRR of mild drinkers with ≤19 g/day of ethanol consumption, whereas an association between serum GGT level and proteinuria was linear. Compared with rare drinkers in the lowest GGT quartile, the subjects in higher GGT quartiles had a higher probability of proteinuria, irrespective of alcohol consumption. An optimal cutoff level of serum GGT was 43.6 and 23.2 IU/L in men and women, respectively.

Conclusions

The subjects with higher serum GGT level had a higher probability of proteinuria, regardless of alcohol consumption, suggesting that GGT has a clinically greater impact on CKD than alcohol consumption.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Briasoulis A, Agarwal V, Messerli FH. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2012;14(11):792–8.CrossRef Briasoulis A, Agarwal V, Messerli FH. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2012;14(11):792–8.CrossRef
2.
Zurück zum Zitat Carlsson S, Hammar N, Grill V. Alcohol consumption and type 2 diabetes meta-analysis of epidemiological studies indicates a U-shaped relationship. Diabetologia. 2005;48(6):1051–4.PubMedCrossRef Carlsson S, Hammar N, Grill V. Alcohol consumption and type 2 diabetes meta-analysis of epidemiological studies indicates a U-shaped relationship. Diabetologia. 2005;48(6):1051–4.PubMedCrossRef
3.
Zurück zum Zitat Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005;28(3):719–25.PubMedCrossRef Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005;28(3):719–25.PubMedCrossRef
4.
Zurück zum Zitat Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123–32.PubMedCentralPubMedCrossRef Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123–32.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012;107(7):1246–60.PubMedCentralPubMedCrossRef Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012;107(7):1246–60.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.PubMedCentralPubMedCrossRef Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289(5):579–88.PubMedCrossRef Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289(5):579–88.PubMedCrossRef
8.
Zurück zum Zitat Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types––a systematic review and meta-analysis. BMC Public Health. 2010;10:258.PubMedCentralPubMedCrossRef Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types––a systematic review and meta-analysis. BMC Public Health. 2010;10:258.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Gunzerath L, Faden V, Zakhari S, Warren K. National institute on alcohol abuse and alcoholism report on moderate drinking. Alcohol Clin Exp Res. 2004;28(6):829–47.PubMedCrossRef Gunzerath L, Faden V, Zakhari S, Warren K. National institute on alcohol abuse and alcoholism report on moderate drinking. Alcohol Clin Exp Res. 2004;28(6):829–47.PubMedCrossRef
10.
Zurück zum Zitat Scouller K, Conigrave KM, Macaskill P, Irwig L, Whitfield JB. Should we use carbohydrate-deficient transferrin instead of gamma-glutamyltransferase for detecting problem drinkers? A systematic review and metaanalysis. Clin Chem. 2000;46(12):1894–902.PubMed Scouller K, Conigrave KM, Macaskill P, Irwig L, Whitfield JB. Should we use carbohydrate-deficient transferrin instead of gamma-glutamyltransferase for detecting problem drinkers? A systematic review and metaanalysis. Clin Chem. 2000;46(12):1894–902.PubMed
11.
Zurück zum Zitat Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004;38(6):535–9.PubMedCrossRef Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004;38(6):535–9.PubMedCrossRef
12.
Zurück zum Zitat Liu CF, Gu YT, Wang HY, Fang NY. Gamma-glutamyltransferase level and risk of hypertension: a systematic review and meta-analysis. PLoS One. 2012;7(11):e48878.PubMedCentralPubMedCrossRef Liu CF, Gu YT, Wang HY, Fang NY. Gamma-glutamyltransferase level and risk of hypertension: a systematic review and meta-analysis. PLoS One. 2012;7(11):e48878.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British women’s heart and health study and meta-analysis. Diabetes Care. 2009;32(4):741–50.PubMedCentralPubMedCrossRef Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British women’s heart and health study and meta-analysis. Diabetes Care. 2009;32(4):741–50.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Du G, Song Z, Zhang Q. Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies. Prev Med. 2013;57(1):31–7.PubMedCrossRef Du G, Song Z, Zhang Q. Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies. Prev Med. 2013;57(1):31–7.PubMedCrossRef
15.
Zurück zum Zitat Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British women’s heart and health study and meta-analysis. Arterioscler Thromb Vasc Biol. 2007;27(12):2729–35.PubMedCrossRef Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British women’s heart and health study and meta-analysis. Arterioscler Thromb Vasc Biol. 2007;27(12):2729–35.PubMedCrossRef
16.
Zurück zum Zitat Hashimoto Y, Futamura A. Relationship between response of gamma-glutamyltransferase to alcohol consumption and levels of fasting plasma glucose. Diabetes Res Clin Pract. 2008;80(3):469–72.PubMedCrossRef Hashimoto Y, Futamura A. Relationship between response of gamma-glutamyltransferase to alcohol consumption and levels of fasting plasma glucose. Diabetes Res Clin Pract. 2008;80(3):469–72.PubMedCrossRef
17.
Zurück zum Zitat Hozawa A, Okamura T, Tanaka T, Miura K, Kikuchi Y, Kadowaki T, et al. Relation of g-glutamyltransferase and alcohol drinking with incident diabetes: the HIPOP-OHP study. J Atheroscler Thromb. 2010;17(2):195–202.PubMedCrossRef Hozawa A, Okamura T, Tanaka T, Miura K, Kikuchi Y, Kadowaki T, et al. Relation of g-glutamyltransferase and alcohol drinking with incident diabetes: the HIPOP-OHP study. J Atheroscler Thromb. 2010;17(2):195–202.PubMedCrossRef
18.
Zurück zum Zitat Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.PubMedCentralPubMedCrossRef Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, et al. Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis. 2010;56(2):313–24.PubMedCrossRef Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, et al. Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis. 2010;56(2):313–24.PubMedCrossRef
20.
Zurück zum Zitat Nagasawa Y, Yamamoto R, Rakugi H, Isaka Y. Cigarette smoking and chronic kidney diseases. Hypertens Res. 2012;35(3):161–5.CrossRef Nagasawa Y, Yamamoto R, Rakugi H, Isaka Y. Cigarette smoking and chronic kidney diseases. Hypertens Res. 2012;35(3):161–5.CrossRef
21.
Zurück zum Zitat Yamamoto R, Nagasawa Y, Iwatani H, Shinzawa M, Obi Y, Teranishi J, et al. Self-reported sleep duration and prediction of proteinuria: a retrospective cohort study. Am J Kidney Dis. 2012;59(3):343–55.PubMedCrossRef Yamamoto R, Nagasawa Y, Iwatani H, Shinzawa M, Obi Y, Teranishi J, et al. Self-reported sleep duration and prediction of proteinuria: a retrospective cohort study. Am J Kidney Dis. 2012;59(3):343–55.PubMedCrossRef
22.
Zurück zum Zitat Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple LS, de Boer I, Sarnak M, et al. Physical activity and rapid decline in kidney function among older adults. Arch Intern Med. 2009;169(22):2116–23.PubMedCentralPubMedCrossRef Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple LS, de Boer I, Sarnak M, et al. Physical activity and rapid decline in kidney function among older adults. Arch Intern Med. 2009;169(22):2116–23.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I. A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study. Hypertens Res. 2013;36(4):328–33.PubMedCrossRef Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I. A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study. Hypertens Res. 2013;36(4):328–33.PubMedCrossRef
24.
Zurück zum Zitat Schaeffner E, Ritz E. Alcohol and kidney damage: a Janus-faced relationship. Kidney Int. 2012;81(9):816–8.PubMedCrossRef Schaeffner E, Ritz E. Alcohol and kidney damage: a Janus-faced relationship. Kidney Int. 2012;81(9):816–8.PubMedCrossRef
25.
Zurück zum Zitat Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, et al. Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008;73(7):870–6.PubMedCrossRef Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, et al. Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008;73(7):870–6.PubMedCrossRef
26.
Zurück zum Zitat White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant. 2009;24(8):2464–72.PubMedCrossRef White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant. 2009;24(8):2464–72.PubMedCrossRef
27.
Zurück zum Zitat Menon V, Katz R, Mukamal K, Kestenbaum B, de Boer IH, Siscovick DS, et al. Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease. Nephrol Dial Transplant. 2010;25(10):3301–7.PubMedCentralPubMedCrossRef Menon V, Katz R, Mukamal K, Kestenbaum B, de Boer IH, Siscovick DS, et al. Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease. Nephrol Dial Transplant. 2010;25(10):3301–7.PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006;164(3):263–71.PubMedCrossRef Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006;164(3):263–71.PubMedCrossRef
29.
Zurück zum Zitat Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159–66.PubMedCrossRef Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159–66.PubMedCrossRef
30.
Zurück zum Zitat Lee DH, Jacobs DR Jr, Gross M, Steffes M. Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the coronary artery risk development in young adults (CARDIA) study. Clin Chem. 2005;51(7):1185–91.PubMedCrossRef Lee DH, Jacobs DR Jr, Gross M, Steffes M. Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the coronary artery risk development in young adults (CARDIA) study. Clin Chem. 2005;51(7):1185–91.PubMedCrossRef
31.
Zurück zum Zitat Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem. 2007;53(1):71–7.PubMedCrossRef Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem. 2007;53(1):71–7.PubMedCrossRef
32.
Zurück zum Zitat Ichikawa K, Konta T, Ikeda A, Fujimoto S, Iseki K, Moriyama T, et al. Significance of past history of renal failure for the detection of high-risk individuals for cardiovascular and end-stage renal disease: analysis of data from a nationwide health checkup. Clin Exp Nephrol. 2011;15(6):841–7.PubMedCrossRef Ichikawa K, Konta T, Ikeda A, Fujimoto S, Iseki K, Moriyama T, et al. Significance of past history of renal failure for the detection of high-risk individuals for cardiovascular and end-stage renal disease: analysis of data from a nationwide health checkup. Clin Exp Nephrol. 2011;15(6):841–7.PubMedCrossRef
33.
Zurück zum Zitat Yano Y, Fujimoto S, Sato Y, Konta T, Iseki K, Moriyama T, et al. Association between prehypertension and chronic kidney disease in the Japanese general population. Kidney Int. 2012;81(3):293–9.PubMedCrossRef Yano Y, Fujimoto S, Sato Y, Konta T, Iseki K, Moriyama T, et al. Association between prehypertension and chronic kidney disease in the Japanese general population. Kidney Int. 2012;81(3):293–9.PubMedCrossRef
34.
Zurück zum Zitat Iseki K, Asahi K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, et al. Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the specific health check and guidance system in Japan 2008. Clin Exp Nephrol. 2012;16(2):244–9.PubMedCrossRef Iseki K, Asahi K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, et al. Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the specific health check and guidance system in Japan 2008. Clin Exp Nephrol. 2012;16(2):244–9.PubMedCrossRef
35.
Zurück zum Zitat Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi K, Moriyama T, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2012;16(2):279–91.PubMedCentralPubMedCrossRef Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi K, Moriyama T, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2012;16(2):279–91.PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Konta T, Ikeda A, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, et al. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort. Am J Hypertens. 2012;25(3):342–7.PubMedCrossRef Konta T, Ikeda A, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, et al. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort. Am J Hypertens. 2012;25(3):342–7.PubMedCrossRef
37.
Zurück zum Zitat Wakasugi M, Narita I, Iseki K, Moriyama T, Yamagata K, Tsuruya K, et al. Weight gain after 20 years of age is associated with prevalence of chronic kidney disease. Clin Exp Nephrol. 2012;16(2):259–68.PubMedCrossRef Wakasugi M, Narita I, Iseki K, Moriyama T, Yamagata K, Tsuruya K, et al. Weight gain after 20 years of age is associated with prevalence of chronic kidney disease. Clin Exp Nephrol. 2012;16(2):259–68.PubMedCrossRef
38.
Zurück zum Zitat Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, Yamagata K et al. U-shaped association between body mass index and proteinuria in a large Japanese general population sample. Clin Exp Nephrol. 2013. In press. Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, Yamagata K et al. U-shaped association between body mass index and proteinuria in a large Japanese general population sample. Clin Exp Nephrol. 2013. In press.
39.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.PubMedCrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.PubMedCrossRef
41.
Zurück zum Zitat Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.PubMedCentralPubMedCrossRef Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.PubMedCentralPubMedCrossRef
42.
Zurück zum Zitat Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):670–5.PubMedCentralPubMedCrossRef Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):670–5.PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468–74.PubMedCrossRef Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468–74.PubMedCrossRef
44.
Zurück zum Zitat Obi Y, Kimura T, Nagasawa Y, Yamamoto R, Yasuda K, Sasaki K, et al. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol. 2010;5(9):1558–65.PubMedCentralPubMedCrossRef Obi Y, Kimura T, Nagasawa Y, Yamamoto R, Yasuda K, Sasaki K, et al. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol. 2010;5(9):1558–65.PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Vupputuri S, Sandler DP. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol. 2003;13(10):712–20.PubMedCrossRef Vupputuri S, Sandler DP. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol. 2003;13(10):712–20.PubMedCrossRef
46.
Zurück zum Zitat Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14(4):479–87.PubMed Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14(4):479–87.PubMed
47.
Zurück zum Zitat Buja A, Scafato E, Baggio B, Sergi G, Maggi S, Rausa G, et al. Renal impairment and moderate alcohol consumption in the elderly. Results from the Italian longitudinal study on aging (ILSA). Public Health Nutr. 2011;14(11):1907–18.PubMedCrossRef Buja A, Scafato E, Baggio B, Sergi G, Maggi S, Rausa G, et al. Renal impairment and moderate alcohol consumption in the elderly. Results from the Italian longitudinal study on aging (ILSA). Public Health Nutr. 2011;14(11):1907–18.PubMedCrossRef
48.
Zurück zum Zitat Knight EL, Stampfer MJ, Rimm EB, Hankinson SE, Curhan GC. Moderate alcohol intake and renal function decline in women: a prospective study. Nephrol Dial Transplant. 2003;18(8):1549–54.PubMedCrossRef Knight EL, Stampfer MJ, Rimm EB, Hankinson SE, Curhan GC. Moderate alcohol intake and renal function decline in women: a prospective study. Nephrol Dial Transplant. 2003;18(8):1549–54.PubMedCrossRef
49.
Zurück zum Zitat Kronborg J, Solbu M, Njolstad I, Toft I, Eriksen BO, Jenssen T. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant. 2008;23(9):2818–26.PubMedCrossRef Kronborg J, Solbu M, Njolstad I, Toft I, Eriksen BO, Jenssen T. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant. 2008;23(9):2818–26.PubMedCrossRef
50.
Zurück zum Zitat Schaeffner ES, Kurth T, de Jong PE, Glynn RJ, Buring JE, Gaziano JM. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med. 2005;165(9):1048–53.PubMedCrossRef Schaeffner ES, Kurth T, de Jong PE, Glynn RJ, Buring JE, Gaziano JM. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med. 2005;165(9):1048–53.PubMedCrossRef
51.
Zurück zum Zitat Stockwell T, Donath S, Cooper-Stanbury M, Chikritzhs T, Catalano P, Mateo C. Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall. Addiction. 2004;99(8):1024–33.PubMedCrossRef Stockwell T, Donath S, Cooper-Stanbury M, Chikritzhs T, Catalano P, Mateo C. Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall. Addiction. 2004;99(8):1024–33.PubMedCrossRef
52.
Zurück zum Zitat Boniface S, Kneale J, Shelton N. Actual and perceived units of alcohol in a self-defined “usual glass” of alcoholic drinks in England. Alcohol Clin Exp Res. 2013;37(6):978–83.PubMedCentralPubMedCrossRef Boniface S, Kneale J, Shelton N. Actual and perceived units of alcohol in a self-defined “usual glass” of alcoholic drinks in England. Alcohol Clin Exp Res. 2013;37(6):978–83.PubMedCentralPubMedCrossRef
53.
54.
Zurück zum Zitat Stickel F, Osterreicher CH. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol. 2006;41(3):209–24.PubMedCrossRef Stickel F, Osterreicher CH. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol. 2006;41(3):209–24.PubMedCrossRef
55.
Zurück zum Zitat Peng GS, Yin SJ. Effect of the allelic variants of aldehyde dehydrogenase ALDH2*2 and alcohol dehydrogenase ADH1B*2 on blood acetaldehyde concentrations. Hum Genomics. 2009;3(2):121–7.PubMedCentralPubMedCrossRef Peng GS, Yin SJ. Effect of the allelic variants of aldehyde dehydrogenase ALDH2*2 and alcohol dehydrogenase ADH1B*2 on blood acetaldehyde concentrations. Hum Genomics. 2009;3(2):121–7.PubMedCentralPubMedCrossRef
56.
Zurück zum Zitat Drogan D, Sheldrick AJ, Schutze M, Knuppel S, Andersohn F, di Giuseppe R, et al. Alcohol consumption, genetic variants in alcohol deydrogenases, and risk of cardiovascular diseases: a prospective study and meta-analysis. PLoS One. 2012;7(2):e32176.PubMedCentralPubMedCrossRef Drogan D, Sheldrick AJ, Schutze M, Knuppel S, Andersohn F, di Giuseppe R, et al. Alcohol consumption, genetic variants in alcohol deydrogenases, and risk of cardiovascular diseases: a prospective study and meta-analysis. PLoS One. 2012;7(2):e32176.PubMedCentralPubMedCrossRef
57.
Zurück zum Zitat Han H, Wang H, Yin Z, Jiang H, Fang M, Han J. Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis. Gene. 2013;526(2):134–41.PubMedCrossRef Han H, Wang H, Yin Z, Jiang H, Fang M, Han J. Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis. Gene. 2013;526(2):134–41.PubMedCrossRef
58.
Zurück zum Zitat Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001;344(8):549–55.PubMedCrossRef Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001;344(8):549–55.PubMedCrossRef
59.
Zurück zum Zitat Younis J, Cooper JA, Miller GJ, Humphries SE, Talmud PJ. Genetic variation in alcohol dehydrogenase 1C and the beneficial effect of alcohol intake on coronary heart disease risk in the second Northwick Park Heart Study. Atherosclerosis. 2005;180(2):225–32.PubMedCrossRef Younis J, Cooper JA, Miller GJ, Humphries SE, Talmud PJ. Genetic variation in alcohol dehydrogenase 1C and the beneficial effect of alcohol intake on coronary heart disease risk in the second Northwick Park Heart Study. Atherosclerosis. 2005;180(2):225–32.PubMedCrossRef
60.
Zurück zum Zitat Shah SV, Baliga R, Rajapurkar M, Fonseca VA. Oxidants in chronic kidney disease. J Am Soc Nephrol. 2007;18(1):16–28.PubMedCrossRef Shah SV, Baliga R, Rajapurkar M, Fonseca VA. Oxidants in chronic kidney disease. J Am Soc Nephrol. 2007;18(1):16–28.PubMedCrossRef
61.
Zurück zum Zitat Hanigan MH, Frierson HF Jr. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. J Histochem Cytochem. 1996;44(10):1101–8.PubMedCrossRef Hanigan MH, Frierson HF Jr. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. J Histochem Cytochem. 1996;44(10):1101–8.PubMedCrossRef
62.
63.
Zurück zum Zitat Ravuri C, Svineng G, Pankiv S, Huseby NE. Endogenous production of reactive oxygen species by the NADPH oxidase complexes is a determinant of gamma-glutamyltransferase expression. Free Radic Res. 2011;45(5):600–10.PubMedCrossRef Ravuri C, Svineng G, Pankiv S, Huseby NE. Endogenous production of reactive oxygen species by the NADPH oxidase complexes is a determinant of gamma-glutamyltransferase expression. Free Radic Res. 2011;45(5):600–10.PubMedCrossRef
64.
Zurück zum Zitat Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med. 2004;37(7):1018–23.PubMedCrossRef Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med. 2004;37(7):1018–23.PubMedCrossRef
65.
Zurück zum Zitat Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis. 2006;189(1):198–205.PubMedCrossRef Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis. 2006;189(1):198–205.PubMedCrossRef
66.
Zurück zum Zitat Nakagawa H, Isogawa A, Tateishi R, Tani M, Yoshida H, Yamakado M, et al. Serum gamma-glutamyltransferase level is associated with serum superoxide dismutase activity and metabolic syndrome in a Japanese population. J Gastroenterol. 2012;47(2):187–94.CrossRef Nakagawa H, Isogawa A, Tateishi R, Tani M, Yoshida H, Yamakado M, et al. Serum gamma-glutamyltransferase level is associated with serum superoxide dismutase activity and metabolic syndrome in a Japanese population. J Gastroenterol. 2012;47(2):187–94.CrossRef
67.
Zurück zum Zitat Turgut O, Tandogan I. Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward. J Atheroscler Thromb. 2011;18(3):177–81.PubMedCrossRef Turgut O, Tandogan I. Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward. J Atheroscler Thromb. 2011;18(3):177–81.PubMedCrossRef
68.
Zurück zum Zitat Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M. gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med. 1998;25(7):786–92.PubMedCrossRef Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M. gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med. 1998;25(7):786–92.PubMedCrossRef
69.
Zurück zum Zitat Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation––a potential mechanism in atherosclerosis. J Investig Med. 1999;47(3):151–60.PubMed Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation––a potential mechanism in atherosclerosis. J Investig Med. 1999;47(3):151–60.PubMed
70.
Zurück zum Zitat Dawson DA, Goldstein RB, Grant BF. Prospective correlates of drinking cessation: variation across the life-course. Addiction. 2013;108(4):712–22.PubMedCentralPubMedCrossRef Dawson DA, Goldstein RB, Grant BF. Prospective correlates of drinking cessation: variation across the life-course. Addiction. 2013;108(4):712–22.PubMedCentralPubMedCrossRef
71.
Zurück zum Zitat Roerecke M, Rehm J. Ischemic heart disease mortality and morbidity rates in former drinkers: a meta-analysis. Am J Epidemiol. 2011;173(3):245–58.PubMedCentralPubMedCrossRef Roerecke M, Rehm J. Ischemic heart disease mortality and morbidity rates in former drinkers: a meta-analysis. Am J Epidemiol. 2011;173(3):245–58.PubMedCentralPubMedCrossRef
72.
Zurück zum Zitat Zambon S, Maggi S, Zanoni S, Romanato G, Noale M, Corti MC, et al. Association of single measurement of estimated glomerular filtration rate and non-quantitative dipstick proteinuria with all-cause and cardiovascular mortality in the elderly. Results from the Progetto Veneto Anziani (Pro.V.A.) Study. Atherosclerosis. 2012;220(1):201–7.PubMedCrossRef Zambon S, Maggi S, Zanoni S, Romanato G, Noale M, Corti MC, et al. Association of single measurement of estimated glomerular filtration rate and non-quantitative dipstick proteinuria with all-cause and cardiovascular mortality in the elderly. Results from the Progetto Veneto Anziani (Pro.V.A.) Study. Atherosclerosis. 2012;220(1):201–7.PubMedCrossRef
73.
Zurück zum Zitat Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol. 2006;17(5):1444–52.PubMedCrossRef Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol. 2006;17(5):1444–52.PubMedCrossRef
Metadaten
Titel
An association between serum γ-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey
verfasst von
Toshihiro Ishigami
Ryohei Yamamoto
Yasuyuki Nagasawa
Yoshitaka Isaka
Hiromi Rakugi
Kunitoshi Iseki
Kunihiro Yamagata
Kazuhiko Tsuruya
Hideaki Yoshida
Shouichi Fujimoto
Koichi Asahi
Issei Kurahashi
Yasuo Ohashi
Toshiki Moriyama
Tsuyoshi Watanabe
Publikationsdatum
01.12.2014
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 6/2014
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-0938-5

Weitere Artikel der Ausgabe 6/2014

Clinical and Experimental Nephrology 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.